Today: 8 June 2026
Browse Category

NYSE:CVS 29 October 2025 - 11 December 2025

CVS Health Stock Surges on 2025–2026 Guidance: Key News, Forecasts and Analysis Since November 21, 2025

CVS Health Stock Surges on 2025–2026 Guidance: Key News, Forecasts and Analysis Since November 21, 2025

CVS Health shares have surged about 70–80% year-to-date in 2025, trading near $80.6 and lifting the company’s market value to just under $100 billion. Q3 revenue rose nearly 8% to $102.9 billion, but a $5.7 billion goodwill impairment drove a GAAP net loss of almost $4 billion. CEO David Joyner will become board chair. CVS reached a $37.8 million federal settlement over insulin pen dispensing.
11 December 2025
··
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health raised its 2025–2026 profit outlook and launched an AI-driven engagement platform at its Investor Day in Hartford, sending shares up 2% to around $78 on December 10. The stock has surged nearly 80% year to date. CVS now expects at least $400 billion in 2025 revenue and adjusted EPS of $6.60–$6.70, above prior guidance. Management projects mid-teens adjusted EPS growth through 2028.
10 December 2025
··
CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Health shares traded near $75.60 on December 6, 2025, after a strong rally and a series of legal settlements, including a $37.8 million insulin pen case and an $18.2 million False Claims Act settlement. A federal judge also ordered CVS Caremark to pay nearly $290 million for Medicare overcharges. Management raised 2025 profit guidance and projected double-digit earnings growth for 2026.
6 December 2025
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health shares fell 1.9% to $77.62 on December 2, 2025, underperforming the S&P 500 and healthcare peers after news of a $37.76 million federal settlement over insulin-pen billing. Trading volume topped 7.7 million shares, above average. The stock remains up about 75–80% for the year but sits roughly 8–9% below its late October high. CVS did not admit liability in the settlement.
3 December 2025
···
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health shares closed at $79.10 on December 1, 2025, down 1.6% and about 7% below their 52-week high. The stock is up nearly 79% year-to-date. Q3 revenue rose 7.8% to $102.9 billion, with adjusted EPS of $1.60 but a GAAP loss per share of –$3.13 due to a $5.7 billion non-cash goodwill impairment. CVS’s trailing P/E ratio spiked above 200 from the one-time charge.
2 December 2025
··
CVS Health Stock Today (NYSE: CVS): Institutional Buying, New Board Chair and Q3 Shock Shape Outlook – November 23, 2025

CVS Health Stock Today (NYSE: CVS): Institutional Buying, New Board Chair and Q3 Shock Shape Outlook – November 23, 2025

CVS Health stock closed Friday at $78.03, up nearly 80% from its 52-week low but still below its high. New 13F filings released Sunday show major institutions, including Handelsbanken Fonder AB and DNB Asset Management AS, increased their stakes in Q2. Institutional investors now hold over 80% of CVS shares. The company is also restructuring its primary care and PBM operations.
23 November 2025
·
Thanksgiving 2025 Store Hours: Is Kroger Open? H‑E‑B Hours, Louisville Malls and Which Stores Are Closed

Thanksgiving 2025 Store Hours: Is Kroger Open? H‑E‑B Hours, Louisville Malls and Which Stores Are Closed

Kroger stores will open on Thanksgiving 2025 with reduced hours, closing by mid-afternoon; pharmacies remain closed. H-E-B will operate 6 a.m. to noon. Louisville malls and most national chains, including Walmart, Target, and Costco, will be closed. Meijer, Food Lion, Whole Foods, and several Albertsons stores will open but close early.
21 November 2025
··········
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk (NVO) Today — Nov. 12, 2025: WeightWatchers to Offer Wegovy Pill, Canada Eyes Ozempic Copies, and the Latest Stock Move

WeightWatchers plans to offer Novo Nordisk’s oral Wegovy in the U.S. after its expected 2026 launch. Sandoz says unbranded Ozempic could reach Canada by June 2026, intensifying price competition. CVS dropped Lilly’s Zepbound from its preferred list, keeping Wegovy, prompting Lilly to move employees off CVS plans. Novo Nordisk shares traded at $49.76 late Wednesday, up slightly.
12 November 2025
·····
1 2 3

Stock Market Today

  • S&P 500 and Nasdaq Rise as Tech and Chip Stocks Rebound
    June 8, 2026, 5:38 PM EDT. The Nasdaq and chipmaker stocks led gains in U.S. markets, as investors capitalized on bargain opportunities after a recent sharp selloff. The rebound followed easing geopolitical tensions between Iran and Israel, boosting market sentiment. This recovery highlights renewed confidence in the technology and semiconductor sectors, which had suffered amid earlier volatility.

Latest articles

UiPath Stock Slips Near $11 as Wall Street Questions the AI Automation Bounce

UiPath Stock Slips Near $11 as Wall Street Questions the AI Automation Bounce

8 June 2026
UiPath shares dipped 0.7% to $11.17 despite a strong quarter and raised outlook, as investors focused on slow annual recurring revenue growth and analyst caution, with Morgan Stanley cutting its price target and BofA maintaining Underperform, citing the need for clearer evidence that AI-driven automation can accelerate durable contract revenue.
IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

8 June 2026
IREN surged 9% to $59.19 as investors returned to crypto and AI infrastructure stocks after last week’s selloff, driven by a $3.65 billion investment-grade GPU financing to support its Microsoft AI cloud contract and news of a planned 800MW data-center in Australia, but future gains hinge on execution, contract delivery, and bitcoin price stability.
SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

8 June 2026
SmartKem shares soared as much as 150% to $1.135 before settling at $0.84 after SRx Health Solutions disclosed a 4.99% stake and purchase of convertible preferred securities, injecting new investor interest as SmartKem faces a Sept. 1 Nasdaq delisting risk for trading below $1 and warns of “substantial doubt” about its ability to continue as a going concern.
Texxon Trading Halted Six Times as NPT Jumps 284% in New York

Texxon Trading Halted Six Times as NPT Jumps 284% in New York

8 June 2026
Texxon shares soared 283.7% to $4.95, briefly topping $12 before closing just below their $5 IPO price, with trading paused six times for volatility and volume over six times shares outstanding; the company warned that similar IPOs had seen sharp, non-fundamental price swings, highlighting ongoing risk for investors.
Social Security Payments Land This Week—June 10 Recipients

Social Security Payments Land This Week—June 10 Recipients

8 June 2026
Social Security’s retirement trust fund could force a 24% benefit cut by 2032, slashing average monthly payments by about $500 for retirees, according to the Committee for a Responsible Federal Budget, as the official trustees project full benefits only until 2033 and continuing income covering just 77% thereafter.
Go toTop